GlassScriptPhysician profile
Jo Lynn Fuller
NPI 1427472083
$1,289.06
in general payments reported to CMS, 2019-2025
21 companies · $46.14 in 2025
The $46.14 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $449 · 2022: $377 · 2023: $266 · 2024: $151 · 2025: $46.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $463.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $271.73 | 2021-2024 | Trintellix |
| Abbvie INC. | $182.10 | 2021-2024 | |
| Astellas Pharma US INC | $119.52 | 2021-2022 | |
| Amgen INC. | $116.22 | 2021-2025 | Evenity, Prolia |
| Pfizer INC. | $69.65 | 2022-2024 | |
| Myriad Women'S Health, INC. | $58.53 | 2023 | Myrisk |
| Organon LLC | $53.56 | 2021-2023 | Nexplanon |
| Novo Nordisk INC | $50.04 | 2021-2022 | |
| Exact Sciences Corporation | $49.26 | 2023-2024 | Cologuard Collection Kit |
| Virtus Pharmaceuticals LLC | $48.05 | 2021 | |
| Therapeuticsmd, INC. | $47.96 | 2021 | |
| Minerva Surgical, INC | $38.47 | 2023 | |
| Merck Sharp & Dohme LLC | $37.94 | 2021 | |
| Sumitomo Pharma America, INC. | $28.00 | 2024 | Gemtesa |
| Lilly USA, LLC | $26.19 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $20.59 | 2023 | Tymlos |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.89 | 2023 | Trulance |
| Acella Pharmaceuticals, LLC | $14.46 | 2023 | NP Thyroid 60 |
| Roche Diagnostics Corporation | $14.38 | 2021 | |
| Azurity Pharmaceuticals, INC. | $12.86 | 2023 | Adthyza |
| Bayer Healthcare Pharmaceuticals INC. | $12.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jo Fuller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.